Last Price Today's Change   Day's Range   Trading Volume
0.055   -0.005 (8.33%)  0.055 - 0.061  425,542


Avg Volume (4 weeks):222,488
4 Weeks Range:0.055 - 0.076
4 Weeks Price Volatility (%):
52 Weeks Range:0.055 - 0.145
52 Weeks Price Volatility (%):
Average Price Target: 2.00
Price Target Upside/Downside: +1.945


No recent Headlines for this stock.

Business Background

Acrux Limited is a drug development company. The Company is engaged in developing and commercializing branded and generic transdermal and topical pharmaceuticals for global markets. The Company's transdermal or topical pharmaceutical product portfolio can be segregated into approximately two streams, such as generic pharmaceutical products and specialty pharmaceutical products. The Company's products include Axiron, Ellavie, Evamist and Lenzetto. Axiron (testosterone) topical solution CIII is a testosterone topical solution approved for application via an armpit (underarm) applicator. It has developed the estradiol spray for women, used to treat moderate to severe hot flushes commonly associated with menopause. In the United States, the Company's estradiol spray is branded Evamist. The Company has licensed its estradiol product to Gedeon Richter to commercialize in various territories, including Europe and Eurasia. Gedeon Richter has branded the estradiol spray as Lenzetto.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

855  825  646  1341 

Top 10 Active Counters
 IMU 0.24+0.075 
 88E 0.007-0.001 
 SYA 0.14+0.015 
 TEM 0.093+0.015 
 EVN 2.64-0.74 
 LKE 0.865+0.06 
 XTC 0.008+0.001 
 AZL 0.09+0.003 
 LRS 0.068+0.002 
 TPD 0.0070.00